Trials / Completed
CompletedNCT05274178
Effect of Hearing Aid Labeling on Speech Understanding Measures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Sonova AG · Industry
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Accepted
Summary
New and experienced hearing aid users will be fit with two hearing devices. One will be labeled as an OTC (Over-The-Counter) device, the other will be labeled as a Prescriptive (i.e. professionally fit) device. Both devices will be generically programmed for a mild to moderate hearing loss. An objective speech in noise test will be completed with both devices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Audeo P hearing aid labeled as "Prescriptive" | The Audeo P is a commercially available hearing aid that is fit by a hearing care professional. The devices will be labeled as "prescriptive" in view of the participant. |
| DEVICE | Audeo P hearing aid labeled as "OTC" | The Audeo P is a commercially available hearing aid that is fit by a hearing care professional. The devices will be labeled as "OTC" in view of the participant. |
Timeline
- Start date
- 2022-05-26
- Primary completion
- 2022-06-16
- Completion
- 2022-06-16
- First posted
- 2022-03-10
- Last updated
- 2023-07-10
- Results posted
- 2023-07-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05274178. Inclusion in this directory is not an endorsement.